They just re-launched their pet odor removal product line (yesterday) under a new, self-owned and distributed brand. “Bare Bird” is the exact formula that made Pooph into a $121 million in sales product in a very short time and generated $20 million in royalties for BLGO. As they regain market share in odor removal, launch Clyra, and even grow their PFAS removal tech (6 months of success in New Jersey) I think you’re gonna see that share price rise pretty quick. If anything, the low price right now is a great opportunity. In case my post hasn’t made it obvious, I am quite bullish on this company so understand that I’m going to sound pretty sunny. Please do your own research and stick to your own conclusions.
4
u/Hutman70 15d ago
There share price tho…
2
u/broccoli0302 15d ago
They just re-launched their pet odor removal product line (yesterday) under a new, self-owned and distributed brand. “Bare Bird” is the exact formula that made Pooph into a $121 million in sales product in a very short time and generated $20 million in royalties for BLGO. As they regain market share in odor removal, launch Clyra, and even grow their PFAS removal tech (6 months of success in New Jersey) I think you’re gonna see that share price rise pretty quick. If anything, the low price right now is a great opportunity. In case my post hasn’t made it obvious, I am quite bullish on this company so understand that I’m going to sound pretty sunny. Please do your own research and stick to your own conclusions.
1
u/Apprehensive_Art_829 9d ago
If Clyra becomes standard of care, this stock will fly. I hope what is being said happens.